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Summary We examined 26 gastric carcinomas from British patients for mutations of the APC gene using a
single-strand conformation polymorphism (SSCP) and heteroduplex assay in conjunction with the protein
truncation test (PTT). In addition, we performed loss of heterozygosity (LOH) analysis of the APC and MCC
genes. We detected an inactivating somatic mutation in one gastric tumour. LOH of APC was observed in one
of 12 informative cases (8%) and of MCC in two of 20 cases (10%). We thus find that alterations of the APC
and MCC genes are infrequent in gastric cancers from the British population. Tumour-suppressor genes on
other chromosomes must play a more significant role in the development of these tumours.
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The development of human cancer is thought to involve an
accumulation of genetic alterations. The alterations asso-
ciated with colorectal cancer are well characterised and a
genetic model of tumour progression has been proposed
(Fearon and Vogelstein, 1990). Inactivation of the tumour-
suppressor gene, APC (adenomatous polyposis coli), is
thought to be an initiating event (Powell et al., 1992).
Germline mutations of the APC gene are responsible for
familial adenomatous polyposis (FAP) (Nishisho et al., 1991;
Groden et al., 1991). Allele loss of another tumour-
suppressor gene, MCC (mutated in colorectal cancer), which
lies in close proximity to APC on chromosome 5q22, is also
frequent and mutations have been described in some
colorectal tumours (Kinzler et al., 1991).
Loss of heterozygosity (LOH) of the 5q21-22 region has
been reported to be frequent in many other human
malignancies including gastric (Sano et al., 1991), oesopha-
geal (Boynton et al., 1992) and lung cancer (D'Amico et al.,
1992). Furthermore, somatic mutations of the APC gene
have been described in several tumour types such as
pancreatic cancer (Horii et al., 1992), oral squamous-cell
carcinoma (Uzawa et al., 1994) and oesophageal cancer
(Powell et al., 1994). In the stomach, APC mutations have
been reported in gastric adenomas (Nakatsuru et al., 1993;
Tamura et al., 1994) and in differentiated and signet-ring
cell carcinomas (Nakatsuru et al., 1992; Maesawa et al.,
1995). These studies have involved analysis of gastric
tumours from Japanese patients. Gastric cancer is not as
prevalent in Britain, probably due to environmental
differences, which may be reflected by a different molecular
pathogenesis.
We decided to examine a series of gastric carcinomas from
UK patients for mutations of the APC gene and for LOH at
sites within the APC and MCC genes. We used single strand
conformation polymorphism (SSCP) and heteroduplex
analysis to screen exons 6, 8, 11, 14 and the 5' half of exon
15 of APC, which includes a region where the majority of
somatic mutations are clustered (mutation cluster region or
MCR) (Miyoshi et al., 1992). In addition, we employed the
protein truncation test (PTT) to screen the MCR for
truncating mutations.
Materials and methods
Tissue specimens and DNA extraction
Twenty-six gastric cancers with corresponding normal
stomach mucosa were obtained from seven hospitals in
London. Twenty-two ofthe patients were UK residents, three
were from the Middle East and one patient was from Brazil.
Tissue samples were flash frozen in liquid nitrogen and then
kept at -70°C until use. The tumours were classified
according to Lauren (1965) : 17 were of the intestinal
histological type and nine of the diffuse type. DNA was
extracted using the Nucleon II DNA extraction kit (Scotlab).
Tumour samples used consisted of more than 50% neoplastic
cells.
Polymerase chain reaction (PCR)
Each reaction consisted of200-500 ng genomic DNA, 50 pM
of each oligonucleotide primer, 0.2 mM dNTPS (Pharmacia),
1 unit Super Taq (HT Biotechnology), Super Taq reaction
buffer (50 mM Tris-HCl, pH 9.0, 50 mM potassium chloride,
7 mM magnesium chloride, 16 mM ammonium sulphate (HT
Biotechnology) in a final volume of 25 ,l. PCR conditions
were denaturation for 4.5 min at 94°C followed by 35 cycles
of 30 s at 94°C, 45 s at optimal annealing temperature (50-
62°C), 45 s at 72°C, and a final elongation of 10 min at 72°C.
SSCP and heteroduplex analysis
The APC gene was screened for mutations with a rapid,
sensitive and non-radioactive method of SSCP and hetero-
duplex analysis using the PhastSystem (Pharmacia) (Gayther
et al., 1995). The 5' half of exon 15 (codons 654- 1700) was
amplified using primer sets (15A-J) described by Groden et
al. (1991). Primer sequences for exons 6, 8, and 14 were
described by Ando et al. (1993) and for exon 11 by Kraus
and Ballhausen (1992). An aliquot of 0.75 ,ul of each PCR
product was diluted with an equal volume of water and
mixed with 1.5 p1 of 95% formamide. This mixture was
denatured at 95°C for 5 min, cooled on ice, and 2 M1 was
used for loading on PhastGel homogenous 20 (20% non-
denaturing polyacrylamide gels) which were used with
PhastGel native buffer strips (Pharmacia). PhastGels were
prerun at 400 V, 20 mA, 2 W, for 10 or 50 volt-hours (Vh).
Electrophoresis was performed at 400 V, 20 mA, 2 W, for
200-300 Vh. Electrophoresis was carried out at either 4, 10,
15 or 20°C depending on which temperature was optimal for
a given PCR fragment. The gels were silver stained, an
automated procedure using the PhastSystem.
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DNA sequencing
DNA templates were prepared by enzymatic treatment of
PCR products with Exonuclease I and shrimp alkaline
phosphatase (Amersham). Direct sequencing was performed
using the Thermosequenase cycle sequencing kit (Amersham).
Protein truncation test (PTT)
DNA template for the in vitro transcription and translation
reaction was generated from genomic DNA using primers
described by Van Der Luijt et al. (1994). The sense primer
included a T7 promoter sequence for transcription initiation
and Kozak consensus sequence for translation initiation at
the 5' end, in frame with APC unique sequence. A 2 kb
product was amplified and used directly in a TNT lysate
coupled transcription/translation reaction (Promega) with
incorporation of 35S-methionine to detect the translation
products, which were then separated on a sodium dodecyl
sulphate (SDS)-polyacrylamide gel with a gradient of 10-
20%. The gels were fixed, dried and autoradiographed at
room temperature.
Detection ofmutations by restriction digest
Some relatively common mutations in exons 6, 8 and 14 alter
the recognition site of restriction enzymes (Ando et al., 1993).
The specific mutation detected together with restriction
enzyme used and size of fragments expected after digestion
of PCR products are given in Table I. Digestion products
were analysed by electrophoresis in 2% agarose gels which
were stained with ethidium bromide and photographed under
UV light.
Table I Detection of mutations in the APC gene by PCR and
restriction enzyme digestion
Size of Size of
normal mutant
alleles alleles
Exon Codon Mutation (bp) (bp) Enzyme
6 232 CGA 137,98 235 AccI
to
TGA
8 302 CGA 134,81 215 TaqI
to
TGA
14 622 TAC 163,140 303 MspI
to
TAA
14 625 CAG 266,37 135,131, MaeI
to 37
TAG
Table II Polymorphic loci analysed for LOH
Polymorphic Polymorphism Method of
locus type detection Allele size
APC exon l1 Rsa IRFLP 3% agarose gel A1=215bp
(codon 486) A2 = 130/85bp
APC exon 15J SSCP Phastgel 317bp
(codon 1678) homogeneous 20
APC 3'UTR SspIRFLP 3% agarose gel Al =270bp
A2 = 135bp
D5S346 (CA),, repeat Phastgel 96-122bp
homogeneous 20
MCC 3'UTR SSCP Phastgel 210bp
homogeneous 20
MCC exon 10 VNTR 3% agarose gel Al =79bp
A2=93bp
Detection of LOH
The APC and MCC genes were investigated for LOH at
polymorphic loci as shown in Table II. For the restriction
fragment length polymorphisms (RFLPs) in exon 11 (Kraus
and Ballhausen, 1992) and the 3' untranslated region
(Heighway et al., 1991) of the APC gene, 10,l of PCR
product was digested with 10 units of restriction enzyme in
40 ,ul for 6 h. Digestion with SspI also gave a band of 580 bp
which thus served as an inbuilt control for complete
digestion. The (CA),, repeat polymorphism (Spirio et al.,
1991) was analysed non-radioactively on the PhastSystem.
The polymorphism in the 3' untranslated region of MCC was
previously analysed by MaeIII digestion (Curtis et al., 1994).
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Figure 1 Detection of a somatic mutation in an intestinal type
gastric carcinoma. a, SSCP and heteroduplex analysis of exon
15H amplicon. Both single strand variants (SS) and heteroduplex
bands (Het) were detected on the gel in tumour DNA (T) from
patient GACA17 that were not present in corresponding normal
DNA (N). b, Sequence analysis of exon 15H amplicon. Results
from both tumour and normal tissue of GACA17 are shown. A
4bp deletion of AGAG or GAGA in GAAAAGAGAGAGAGT
at codon 1462-1465 results in a frameshift in the tumour DNA
sequence and the formation of an early stop codon downstream
of the mutation. The sequence of the antisense strand is shown.
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No restriction digestion was needed for the variable number
of tandem repeats (VNTR) polymorphism in exon 10 of
MCC (Greenwald et al., 1992). Only patients who showed
constitutional heterozygosity at a given locus were considered
informative for this study.
Results
SSCP and heteroduplex analysis
We analysed over 40% ofthe coding region ofthe APC gene.
A somatic variant was detected in one of 26 gastric cancers
(4%) as shown in Figure la. This was an intestinal type
tumour (GACA17). Subsequent sequencing revealed that we
had detected a 4 bp deletion of either AGAG or GAGA in
the sequence GAAAAGAGAGAGAGT at codon 1462-
1465 (Figure lb). This mutation was located within the MCR
(codons 1286-1513). The deletion was predicted to lead to
truncation of the protein product due to the formation of an
early stop codon.
Protein truncation
APC protein corresponding to codons 1028-1700 was
synthesised in vitro in a coupled transcription and translation
reaction in order to detect protein-truncating mutations. A
truncated peptide was detected in tumour GACA17 (Figure
2). This gastric cancer showed the normal sized in vitro
translation product of 67 kDa as well as a 44 kDa product.
This shorter peptide corresponded in size to the mutant
protein expected to be produced as a result of the deletion at
codon 1462- 1465 that we had previously detected by SSCP
and heteroduplex analysis in this tumour, which thus served
as a positive control. However, truncated proteins were not
detected in the rest of our tumour series.
Restriction digest analysis for mutation detection
PCR products digested with the appropriate restriction
enzyme were analysed for specific chain-terminating muta-
tions (Ando et al., 1993) in exons 6, 8 and 14. However, no
mutations were detected in gastric cancers.
(&ACA17 r.ACA1R (;ACA19
67 kDa
44 kDa
Figure 2 Detection of protein truncating mutation by PTT. The
normal protein product of 67kDa is present in all the gastric
tumours. Only tumour GACA17 has a truncating mutation,
giving rise to a shorter peptide of 44kDa.
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Figure 3 LOH at the APC and MCC loci in gastric cancers.
Complete or partial loss of intensity of a band in tumour DNA
indicated LOH. (a) Rsa I RFLP in APC exon 11. The undigested
allele (215 bp band) is present in both normal (N) and tumour (T)
DNA from patient GACA23. Loss of the digested allele (130 and
85bp bands) is seen in tumour DNA. (b) SSCP analysis of
polymorphism in MCC 3'UTR. LOH is indicated by the arrow.
(c) A 14bp insertion/deletion polymorphism in MCC exon 10
gives rise to a 93 or 79bp allele. Loss of the 79bp allele is seen in
the tumour. Remaining signals are probably due to the presence
of contaminating normal cells in the tumour specimen.
Loss of heterozygosity
Allele loss of the APC and MCC genes was investigated at
intragenic polymorphic loci. LOH of APC was detected in
one of 12 informative cases (8%) and of MCC in two of 20
informative cases (10%) (Figure 3). Table III summarises
the results of the LOH analysis. At the APC gene locus
LOH was found in one of 10 informative intestinal-type
tumours (10%) but in neither of two informative diffuse-
type tumours. As there was a low percentage of
heterozygosity at intragenic polymorphic loci for diffuse
gastric cancers, these tumours were also investigated for
LOH using a microsatellite repeat marker closely linked to
the APC gene, D5S346. However, no LOH was detected in
eight of nine diffuse tumours that were informative at this
locus. At the MCC gene locus LOH was detected in two of
12 informative intestinal-type tumours (16.7%) but in none
of eight informative diffuse tumours.
Discussion
Little is known about which genetic alterations are significant
in gastric cancer and, in contrast to colorectal cancer, no
clear sequence of genetic changes has been elucidated.
Genetic changes that have been reported include LOH on
chromosomes lq, 5q, 17p (Sano et al., 1991), 7q (Kuniyasu et
al., 1994) and 18q (Uchino et al., 1992), amplification of the
erbB-2 oncogene (Park et al., 1989) and mutations of the
TP53 gene (Renault et al., 1993). The incidence of mutations
of the APC gene in gastric cancer needs to be evaluated.
Table m Results of LOH analysis at the APC and MCC gene loci
in 17 intestinal type and 9 diffuse type gastric cancers
Histological
Patient typea APC LOHb MCC LOH
GACAI D HOM HET
GACA2 D HOM HET
GACA3 I HET HOM
GACA4 I HET HET
GACA5 D HOM HOM
GACA6 D HET HET
GACA7 D HOM HET
GACA8 I HOM HOM
GACA9 D HOM HET
GACAIO I HET HOM
GACAl1 I HOM HET
GACA12 I HET HET
GACA13 I HOM HET
GACA14 I HOM HET
GACA15 I HOM LOH
GACA16 I HOM HET
GACA17 I HET HET
GACA18 D HET HET
GACA19 D HOM HET
GACA20 I HET HET
GACA21 I HET HET
GACA22 I HET HOM
GACA23 I LOH HOM
GACA24 D HOM HET
GACA25 I HOM HET
GACA26 I HET LOH
aD, diffuse type; I, intestinal type. bHOM, homozygous; HET,
constitutional heterozygosity retained; LOH, loss ofheterozygosity.APC and MCC gone alterations in gastric cancer
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We detected a somatic mutation of APC in only one of 26
(4%) gastric carcinomas. This was an intestinal-type tumour.
Nakatsuru et al. (1992) identified APC gene mutations in 12
of 57 (21%) gastric cancers by RNAase protection analysis.
These were differentiated carcinomas (intestinal-type accord-
ing to classification of Lauren) and signet-ring cell
carcinomas. However, no mutations were detected in 24
gastric carcinomas by Ogasawara et al. (1994) using SSCP
analysis. In a larger study, these authors later found APC to
be mutated in only one of 72 (1.4%) gastric cancers, a signet-
ring cell carcinoma (Maesawa et al., 1995). Considering these
results it is probable that APC gene mutations do not occur
in the majority of gastric cancers. They may be frequent only
in certain histopathological types. APC mutations have been
detected in 20-40% of gastric adenomas (Nakatsuru et al.,
1993; Tamura et al., 1994), which are thought to be
precursors of some differentiated types of gastric cancer.
Nakatsuru et al. (1992) divided differentiated-type carcinomas
into 'very well-differentiated' and 'well-or moderately
differentiated' types and found mutations were significantly
more frequent in the very well-differentiated carcinoma.
We analysed the 5' half of exon 15 as did the above
authors because the majority of mutations have been
localised to this part of the gene and it includes a region
where two-thirds of somatic mutations in colorectal tumours
are clustered (MCR) (Nagase and Nakamura, 1993). The
mutation we identified was located at a particular hotspot in
this region (codon 1462-1465). A similar mutation at this
position was identified in two flat adenomas of the stomach
by Nakatsuru et al. (1993). We screened four earlier exons in
addition by SSCP and heteroduplex analysis and by
restriction digest analysis for specific mutations, but failed
to detect any mutants. It remains possible that mutations in
gastric carcinomas are frequent in areas of the gene other
than those that correspond to mutation cluster regions in
colorectal carcinomas. We did observe LOH of APC in one
gastric tumour (Table III), which may have harboured a
mutation in the other APC allele in accordance with
Knudson's hypothesis (Knudson, 1971).
We used a combination of mutation detection methods.
Our SSCP and heteroduplex analysis was automated, which
allowed optimal and precise control of electrophoretic
conditions. We have previously found this assay to be
efficient in the detection of germline mutations and
polymorphic variants in FAP patients (Gayther et al., 1994,
1995). We employed the PTT as a secondary screening
technique to detect chain-terminating mutations as the great
majority of mutations in APC lead to truncation of the
protein product (Nagase and Nakamura, 1993). The
combination of these techniques has led to the detection of
causative APC germline mutations in 66% of families studied
(Wells et al., unpublished observations). Approximately half
of the APC mutations detected in gastric carcinomas by
Nakatsuru et al. (1992) using RNAase protection analysis
were missense mutations. The sensitivity of SSCP for the
detection of single base substitutions has been reported to be
greatest for molecules shorter than 200 bp (Sheffield et al.,
1993). In our study PCR fragments for exon 15A-J, generated
using primer sets described by Groden et al. (1991), were
larger in size (312-508 bp). It cannot be excluded that this
led to a decreased sensitivity of base substitution and hence
missense mutation detection. We have, however, found that
seven of 17 somatic variants identified in 16 sporadic
colorectal cancers in exon 15A-J using the same SSCP
conditions as the present study, were the result of single base
changes (Sud et al., unpublished data).
This is the first report on mutations of the APC gene in
gastric cancers from Western patients. We think that APC
mutations occur only in the minority of gastric cancers from
both British and Japanese patients. We observed LOH of
APC in only 8% of cases, and of MCC in 10% of cases.
LOH of MCC occurred independently of APC in one case
(Table III). The incidence of LOH of chromosome 5q is
higher in Japanese gastric cancers (87% of cases by Tamura
et al., 1993; 42% ofwell-differentiated carcinomas by Sano et
al., 1991). It is possible that mutations in a tumour-
suppressor gene(s) on chromosome 5q other than APC is
responsible for the frequent LOH, as has been suggested for
other solid tumours (Horii et al., 1992; Powell et al., 1994),
possibly MCC. We do not think this would be a significant
event in our tumours as the incidence of 5q-LOH (12.5% of
cases) is very low. In a smaller study on gastric carcinomas
from the UK, Fey et al. (1989) also described infrequent
LOH on chromosome 5q (10% ofcases). It therefore appears
that some molecular differences may exist between British
and Japanese gastric cancers.
We did not detect any alterations in diffuse-type cancers.
This histological type usually contains a higher proportion of
non-neoplastic stromal cells which can inhibit the detection of
genetic alterations. In this study only tumour samples that
contained mainly malignant cells (>50%) as determined by
cryostat sectioning were used. However, alterations of APC
and MCC were also infrequent in intestinal-type tumours.
We conclude that tumour-suppressor genes on other
chromosomes must play a more important role in the
development of gastric cancer in patients from the British
population.
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